| Year |
Citation |
Score |
| 2023 |
Yeap ZJS, Marsault J, George TP, Mizrahi R, Rabin RA. Does tobacco dependence worsen cannabis withdrawal in people with and without schizophrenia-spectrum disorders? The American Journal On Addictions. PMID 36815595 DOI: 10.1111/ajad.13394 |
0.37 |
|
| 2022 |
Tonkin SS, Colder C, Mahoney MC, Swan GE, Cinciripini P, Schnoll R, George TP, Tyndale RF, Hawk LW. Evaluating Treatment Mechanisms of Varenicline: Mediation by Affect and Craving. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 35639828 DOI: 10.1093/ntr/ntac138 |
0.357 |
|
| 2022 |
Johnstone S, Sorkhou M, Rabin RA, George TP. Dose-dependent effects of Varenicline on tobacco craving and withdrawal in tobacco smokers with and without schizophrenia. Drug and Alcohol Dependence. 234: 109412. PMID 35395548 DOI: 10.1016/j.drugalcdep.2022.109412 |
0.457 |
|
| 2021 |
Wickens CM, Mann RE, Brands B, Stoduto G, Matheson J, Sayer G, Burston J, Pan JF, Di Ciano P, George TP, Rehm J, Kenney C, Soule D, Huestis MA, Le Foll B. Influence of personality on acute smoked cannabis effects on simulated driving. Experimental and Clinical Psychopharmacology. PMID 34291988 DOI: 10.1037/pha0000505 |
0.32 |
|
| 2021 |
Schnoll R, Paul Wileyto E, Bauer AM, Fox E, Leone F, Lerman C, Tyndale RF, George TP, Hawk L, Cinciripini P, Quinn M, Purnell J, Hatzell J, Hitsman B. Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder. The American Journal On Addictions. PMID 33772971 DOI: 10.1111/ajad.13155 |
0.368 |
|
| 2020 |
Ashare RL, Wileyto EP, Logue-Chamberlain E, Gross R, Tyndale RF, Lerman C, Hawk LW, Cinciripini P, George TP, Lubitz SF, Schnoll R. Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 32686950 DOI: 10.1037/Adb0000619 |
0.31 |
|
| 2020 |
Matheson J, Mann RE, Sproule B, Huestis MA, Wickens CM, Stoduto G, George TP, Rehm J, Le Foll B, Brands B. Acute and residual mood and cognitive performance of young adults following smoked cannabis. Pharmacology, Biochemistry, and Behavior. 172937. PMID 32360692 DOI: 10.1016/J.Pbb.2020.172937 |
0.405 |
|
| 2020 |
Schnoll R, Paul Wileyto E, Gross R, Hitsman B, Hawk LW, Cinciripini P, George TP, Benowitz NL, Fen Lubitz S, Ashare R, Tyndale RF, Lerman C. Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. Drug and Alcohol Dependence. 210: 107967. PMID 32224420 DOI: 10.1016/J.Drugalcdep.2020.107967 |
0.419 |
|
| 2020 |
Buchwald J, Chenoweth MJ, Palviainen T, Zhu G, Benner C, Gordon S, Korhonen T, Ripatti S, Madden PAF, Lehtimäki T, Raitakari OT, Salomaa V, Rose RJ, George TP, Lerman C, et al. Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. Molecular Psychiatry. PMID 32157176 DOI: 10.1038/S41380-020-0702-Z |
0.456 |
|
| 2020 |
Kozak K, George TP. Pharmacotherapy for smoking cessation in schizophrenia: a systematic review. Expert Opinion On Pharmacotherapy. 1-10. PMID 32011186 DOI: 10.1080/14656566.2020.1721466 |
0.543 |
|
| 2020 |
Lowe D, Kozak K, George T. Neuropsychological and Neurophysiological Measures Associated With Changes in Cannabis Use and rTMS Treatment Response in Schizophrenia Biological Psychiatry. 87. DOI: 10.1016/J.Biopsych.2020.02.1085 |
0.366 |
|
| 2019 |
Brands B, Mann RE, Wickens CM, Sproule B, Stoduto G, Sayer GS, Burston J, Pan JF, Matheson J, Stefan C, George TP, Huestis MA, Rehm J, Le Foll B. Acute and residual effects of smoked cannabis: Impact on driving speed and lateral control, heart rate, and self-reported drug effects. Drug and Alcohol Dependence. 205: 107641. PMID 31678833 DOI: 10.1016/J.Drugalcdep.2019.107641 |
0.414 |
|
| 2019 |
Botsford SL, Yang S, George TP. Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential. The American Journal On Addictions. PMID 31577377 DOI: 10.1111/Ajad.12963 |
0.308 |
|
| 2019 |
Kozak K, Lowe DJE, George TP. Effects of Tobacco Smoking Status on Verbal Learning and Memory in Patients With Schizophrenia and Non-Psychiatric Controls. The American Journal On Addictions. PMID 31291035 DOI: 10.1111/Ajad.12903 |
0.46 |
|
| 2019 |
Coles AS, Sasiadek J, George TP. Pharmacotherapies for Co-Occurring Substance Use and Bipolar Disorders: A Systematic Review. Bipolar Disorders. PMID 31077521 DOI: 10.1111/Bdi.12794 |
0.358 |
|
| 2019 |
Le TL, Conklin CA, George TP, Levitan RD, Mann RE, Maunder RG. Exposure to attachment figure cue reduces cigarette craving. Experimental and Clinical Psychopharmacology. PMID 31070429 DOI: 10.1037/Pha0000284 |
0.348 |
|
| 2019 |
Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). 33: 1083-1088. PMID 30946162 DOI: 10.1097/Qad.0000000000002127 |
0.392 |
|
| 2019 |
Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 30614717 DOI: 10.1037/Adb0000434 |
0.472 |
|
| 2018 |
Lucatch AM, Coles AS, Hill KP, George TP. Cannabis and Mood Disorders. Current Addiction Reports. 5: 336-345. PMID 30643708 DOI: 10.1007/S40429-018-0214-Y |
0.314 |
|
| 2018 |
Lucatch AM, Lowe DJE, Clark RC, Kozak K, George TP. Neurobiological Determinants of Tobacco Smoking in Schizophrenia. Frontiers in Psychiatry. 9: 672. PMID 30574101 DOI: 10.3389/Fpsyt.2018.00672 |
0.553 |
|
| 2018 |
Lowe DJE, Sasiadek JD, Coles AS, George TP. Cannabis and mental illness: a review. European Archives of Psychiatry and Clinical Neuroscience. PMID 30564886 DOI: 10.1007/S00406-018-0970-7 |
0.359 |
|
| 2018 |
Kozak K, Lucatch AM, Lowe DJE, Balodis IM, MacKillop J, George TP. The neurobiology of impulsivity and substance use disorders: implications for treatment. Annals of the New York Academy of Sciences. PMID 30291624 DOI: 10.1111/Nyas.13977 |
0.34 |
|
| 2018 |
Gendy MNS, Di Ciano P, Kowalczyk WJ, Barrett SP, George TP, Heishman S, Le Foll B. Testing the PPAR hypothesis of tobacco use disorder in humans: A randomized trial of the impact of gemfibrozil (a partial PPARα agonist) in smokers. Plos One. 13: e0201512. PMID 30260990 DOI: 10.1371/Journal.Pone.0201512 |
0.454 |
|
| 2018 |
Peng AR, Schnoll R, Hawk LW, Cinciripini P, George TP, Lerman C, Tyndale RF. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. Drug and Alcohol Dependence. 190: 72-81. PMID 29986268 DOI: 10.1016/J.Drugalcdep.2018.04.035 |
0.355 |
|
| 2018 |
Taghavi T, Novalen M, Lerman C, George TP, Tyndale RF. A comparison of direct and indirect analytical approaches to measuring total nicotine equivalents in urine. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29853480 DOI: 10.1158/1055-9965.Epi-18-0018 |
0.307 |
|
| 2018 |
Ramlakhan JU, Zomorrodi R, Downar J, Blumberger DM, Daskalakis ZJ, George TP, Kiang M, Barr MS. Using Mismatch Negativity to Investigate the Pathophysiology of Substance Use Disorders and Comorbid Psychosis. Clinical Eeg and Neuroscience. 1550059418760077. PMID 29502434 DOI: 10.1177/1550059418760077 |
0.363 |
|
| 2018 |
Kozak K, Sharif-Razi M, Morozova M, Gaudette EV, Barr MS, Daskalakis ZJ, Blumberger DM, George TP. Effects of short-term, high-frequency repetitive transcranial magnetic stimulation to bilateral dorsolateral prefrontal cortex on smoking behavior and cognition in patients with schizophrenia and non-psychiatric controls. Schizophrenia Research. PMID 29486960 DOI: 10.1016/J.Schres.2018.02.015 |
0.508 |
|
| 2018 |
Rabin RA, Dermody SS, George TP. Changes in tobacco consumption in cannabis dependent patients with schizophrenia versus non-psychiatric controls during 28-days of cannabis abstinence. Drug and Alcohol Dependence. 185: 181-188. PMID 29459327 DOI: 10.1016/J.Drugalcdep.2017.12.017 |
0.484 |
|
| 2018 |
Trigo JM, Soliman A, Quilty LC, Fischer B, Rehm J, Selby P, Barnes AJ, Huestis MA, George TP, Streiner DL, Staios G, Le Foll B. Nabiximols combined with motivational enhancement/cognitive behavioral therapy for the treatment of cannabis dependence: A pilot randomized clinical trial. Plos One. 13: e0190768. PMID 29385147 DOI: 10.1371/Journal.Pone.0190768 |
0.332 |
|
| 2017 |
Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF, et al. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction (Abingdon, England). PMID 28921760 DOI: 10.1111/Add.14032 |
0.395 |
|
| 2017 |
Peng AR, Morales M, Wileyto EP, Hawk LW, Cinciripini P, George TP, Benowitz NL, Nollen NL, Lerman C, Tyndale RF, Schnoll R. Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addictive Behaviors. 75: 122-129. PMID 28728040 DOI: 10.1016/J.Addbeh.2017.07.006 |
0.394 |
|
| 2017 |
Samokhvalov AV, Awan S, George TP, Irving J, Le Foll B, Perrotta S, Probst C, Voore P, Rehm J. Integrated care pathway for co-occurring major depressive and alcohol use disorders: Outcomes of the first two years. The American Journal On Addictions. PMID 28570773 DOI: 10.1111/Ajad.12572 |
0.304 |
|
| 2017 |
Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll RA. Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? Journal of Smoking Cessation. 12: 63-70. PMID 28553407 DOI: 10.1017/Jsc.2016.11 |
0.351 |
|
| 2017 |
Rabin RA, Kozak K, Zakzanis KK, Remington G, Stefan C, Budney AJ, George TP. A method to achieve extended cannabis abstinence in cannabis dependent patients with schizophrenia and non-psychiatric controls. Schizophrenia Research. PMID 28506704 DOI: 10.1016/J.Schres.2017.05.006 |
0.398 |
|
| 2017 |
Rabin RA, Barr MS, Goodman MS, Herman Y, Zakzanis KK, Kish SJ, Kiang M, Remington G, George TP. Effects of Extended Cannabis Abstinence on Cognitive Outcomes in Cannabis Dependent Patients with Schizophrenia versus Non-Psychiatric Controls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. PMID 28443616 DOI: 10.1038/Npp.2017.85 |
0.399 |
|
| 2017 |
Noda Y, Barr MS, Zomorrodi R, Cash RF, Rajji TK, Farzan F, Chen R, George TP, Daskalakis ZJ, Blumberger DM. Reduced Short-latency Afferent Inhibition in Prefrontal but not Motor Cortex and its Association With Executive Function in Schizophrenia: A Combined TMS-EEG Study. Schizophrenia Bulletin. PMID 28379529 DOI: 10.1093/Schbul/Sbx041 |
0.332 |
|
| 2017 |
Kozak K, Dermody SS, Rabin RA, Zack M, Barr MS, Tyndale RF, George TP. Effects of varenicline on cognitive function in non-smokers with schizophrenia. Schizophrenia Research. PMID 28291692 DOI: 10.1016/J.Schres.2017.03.023 |
0.406 |
|
| 2017 |
Rabin RA, Kozak K, Zakzanis KK, Remington G, George TP. Effects of extended cannabis abstinence on clinical symptoms in cannabis dependent schizophrenia patients versus non-psychiatric controls. Schizophrenia Research. PMID 28285022 DOI: 10.1016/J.Schres.2017.03.010 |
0.412 |
|
| 2017 |
Riad-Allen L, Dermody SS, Herman Y, Bellissimo K, Selby P, George TP. Becoming tobacco-free: Changes in staff and patient attitudes and incident reports in a large academic mental health and addictions hospital. The American Journal On Addictions. PMID 28211960 DOI: 10.1111/Ajad.12513 |
0.335 |
|
| 2017 |
Le TL, Mann RE, Levitan RD, George TP, Maunder RG. Sex differences in the relationships between childhood adversity, attachment anxiety and current smoking Addiction Research & Theory. 25: 146-153. DOI: 10.1080/16066359.2016.1233968 |
0.466 |
|
| 2017 |
Kozak K, Barr M, George T. 192. Effect of Varenicline Doses and Plasma Levels on Cognitive Function in Non-Smokers with Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.205 |
0.372 |
|
| 2017 |
Gaudette E, Kozak K, Barr M, George T. 176. The Effects of Repetitive Transcranial Magnetic Stimulation (rTMS) on Smoking Behaviour and Cognition in Smokers with Schizophrenia versus Non-Psychiatric Control Smokers Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.189 |
0.496 |
|
| 2017 |
Coles A, Kozak K, Sharif-Razi M, McKee S, George T. 175. Effects of the Nicotinic Partial Agonist Varenicline on Smoking Lapse in Smokers with and without Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.188 |
0.533 |
|
| 2017 |
Barr M, Zomorrodi R, Goodman M, Kozak K, Ramlakan J, Coles A, Gaudette E, Rajji TK, George T. 678. Differential Effects of Cannabis versus Tobacco on Theta-Gamma Coupling in Schizophrenia Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.1087 |
0.402 |
|
| 2017 |
Kozak K, Barr MS, George TP. Traits and Biomarkers for Addiction Risk in Schizophrenia Current Addiction Reports. 4: 14-24. DOI: 10.1007/S40429-017-0130-6 |
0.388 |
|
| 2016 |
Goodman MS, Bridgman AC, Rabin RA, Blumberger DM, Rajji TK, Daskalakis ZJ, George TP, Barr MS. Differential effects of cannabis dependence on cortical inhibition in patients with schizophrenia and non-psychiatric controls. Brain Stimulation. PMID 27964871 DOI: 10.1016/J.Brs.2016.11.004 |
0.372 |
|
| 2016 |
Bridgman AC, Barr MS, Goodman MS, Zomorrodi R, Rajji T, Le Foll B, Chen R, Daskalakis ZJ, George TP. Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia. Schizophrenia Research. PMID 27613505 DOI: 10.1016/J.Schres.2016.08.031 |
0.473 |
|
| 2016 |
Rabin RA, George TP. Cannabis and psychosis: understanding the smoke signals. The Lancet. Psychiatry. PMID 27567466 DOI: 10.1016/S2215-0366(16)30230-9 |
0.454 |
|
| 2016 |
Trigo JM, Soliman A, Staios G, Quilty L, Fischer B, George TP, Rehm J, Selby P, Barnes AJ, Huestis MA, Le Foll B. Sativex Associated With Behavioral-Relapse Prevention Strategy as Treatment for Cannabis Dependence: A Case Series. Journal of Addiction Medicine. PMID 27261670 DOI: 10.1097/Adm.0000000000000229 |
0.307 |
|
| 2016 |
Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW, Lerman C, Tyndale RF, George TP. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 27187893 DOI: 10.1111/Ajad.12382 |
0.497 |
|
| 2016 |
Ross KC, Gubner NR, Tyndale RF, Hawk LW, Lerman C, George TP, Cinciripini P, Schnoll RA, Benowitz NL. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacology, Biochemistry, and Behavior. PMID 27180107 DOI: 10.1016/J.Pbb.2016.05.002 |
0.387 |
|
| 2016 |
Bridgman AC, Barr MS, Goodman MS, Chen R, Rajji TK, Daskalakis ZJ, George TP. Deficits in GABAA receptor function and working memory in non-smokers with schizophrenia. Schizophrenia Research. PMID 26796540 DOI: 10.1016/J.Schres.2016.01.008 |
0.383 |
|
| 2016 |
Kozak K, Barr M, George T. Effect of varenicline on cognitive function in non-smokers with schizophrenia F1000research. 5. DOI: 10.7490/F1000Research.1111969.1 |
0.406 |
|
| 2016 |
Halah MP, Zochniak MP, Barr MS, George TP. Cannabis Use and Psychiatric Disorders: Implications for Mental Health and Addiction Treatment Current Addiction Reports. 3: 450-462. DOI: 10.1007/S40429-016-0128-5 |
0.346 |
|
| 2015 |
Chen S, Awan S, Rajji T, Abdool P, George TP, Collins A, Kidd SA. Integrated Care Pathways for Schizophrenia: A Scoping Review. Administration and Policy in Mental Health. PMID 26512011 DOI: 10.1007/S10488-015-0696-Z |
0.33 |
|
| 2015 |
Morozova M, Rabin RA, George TP. Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers. The American Journal On Addictions. 24: 687-94. PMID 26354720 DOI: 10.1111/ajad.12277 |
0.352 |
|
| 2015 |
Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW, George TP, Cinciripini PM, Lerman C, Tyndale RF. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26069034 DOI: 10.1093/Ntr/Ntv125 |
0.456 |
|
| 2015 |
Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26014804 DOI: 10.1158/1055-9965.Epi-14-1381 |
0.416 |
|
| 2015 |
Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Plos One. 10: e0128109. PMID 26010901 DOI: 10.1371/Journal.Pone.0128109 |
0.454 |
|
| 2015 |
Rabin RA, George TP. A review of co-morbid tobacco and cannabis use disorders: possible mechanisms to explain high rates of co-use. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 24: 105-16. PMID 25662704 DOI: 10.1111/Ajad.12186 |
0.459 |
|
| 2015 |
Forrest PE, Brinson AJ, Gannon JM, George TP, Perkins KA, Chengappa KN. An association between the use of hypnotics and quit status in the treatment of nicotine dependence with varenicline in bipolar disorder. Journal of Clinical Psychopharmacology. 35: 199-200. PMID 25627075 DOI: 10.1097/Jcp.0000000000000272 |
0.521 |
|
| 2015 |
Lerman C, Schnoll RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NL, Heitjan DF, Tyndale RF. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. The Lancet. Respiratory Medicine. 3: 131-8. PMID 25588294 DOI: 10.1016/S2213-2600(14)70294-2 |
0.456 |
|
| 2015 |
Wing VC, Payer DE, Houle S, George TP, Boileau I. Measuring cigarette smoking-induced cortical dopamine release: A [¹¹C]FLB-457 PET study. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1417-27. PMID 25502631 DOI: 10.1038/Npp.2014.327 |
0.449 |
|
| 2015 |
Bridgman A, Barr M, Goodlman M, Zomorrodi R, Rajji T, Daskalakis Z, George T. Deficits in GABAa receptor function and working memory performance in non-smokers with schizophrenia F1000research. 6. DOI: 10.7490/F1000Research.1098113.1 |
0.36 |
|
| 2015 |
Morozova M, Rabin RA, George TP. Co-morbid tobacco use disorder and depression: A re-evaluation of smoking cessation therapy in depressed smokers American Journal On Addictions. 24: 687-694. DOI: 10.1111/Ajad.12277 |
0.467 |
|
| 2014 |
Barr MS, George TP. Deep repetitive transcranial magnetic stimulation for smoking cessation: is going deeper better? Biological Psychiatry. 76: 678-80. PMID 25282533 DOI: 10.1016/J.Biopsych.2014.08.003 |
0.444 |
|
| 2014 |
Rabin RA, Giddens JL, George TP. Relationship between tobacco and cannabis use status in outpatients with schizophrenia. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 23: 170-5. PMID 25187052 DOI: 10.1111/J.1521-0391.2013.12084.X |
0.514 |
|
| 2014 |
Chenoweth MJ, Novalen M, Hawk LW, Schnoll RA, George TP, Cinciripini PM, Lerman C, Tyndale RF. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1773-82. PMID 25012994 DOI: 10.1158/1055-9965.Epi-14-0427 |
0.412 |
|
| 2014 |
Chengappa KN, Perkins KA, Brar JS, Schlicht PJ, Turkin SR, Hetrick ML, Levine MD, George TP. Varenicline for smoking cessation in bipolar disorder: a randomized, double-blind, placebo-controlled study. The Journal of Clinical Psychiatry. 75: 765-72. PMID 25006684 DOI: 10.4088/Jcp.13M08756 |
0.487 |
|
| 2014 |
Schnoll RA, George TP, Hawk L, Cinciripini P, Wileyto P, Tyndale RF. The relationship between the nicotine metabolite ratio and three self-report measures of nicotine dependence across sex and race. Psychopharmacology. 231: 2515-23. PMID 24402139 DOI: 10.1007/S00213-013-3421-1 |
0.374 |
|
| 2014 |
Le Foll B, Guranda M, Wilson AA, Houle S, Rusjan PM, Wing VC, Zawertailo L, Busto U, Selby P, Brody AL, George TP, Boileau I. Elevation of dopamine induced by cigarette smoking: novel insights from a [11C]-+-PHNO PET study in humans. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 415-24. PMID 23954846 DOI: 10.1038/Npp.2013.209 |
0.462 |
|
| 2014 |
Mackowick KM, Barr MS, Wing VC, Rabin RA, Ouellet-Plamondon C, George TP. Neurocognitive endophenotypes in schizophrenia: modulation by nicotinic receptor systems. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 52: 79-85. PMID 23871750 DOI: 10.1016/J.Pnpbp.2013.07.010 |
0.495 |
|
| 2014 |
Bridgman AC, Mackowick KM, Goodman MS, Rabin RA, Barr MS, George TP. Translating Neurobiology to the Treatment of Dual Diagnosis: The Example of Nicotinic Receptors and Neurocognitive Endophenotypes in Schizophrenia Current Addiction Reports. 1: 272-280. DOI: 10.1007/S40429-014-0033-8 |
0.535 |
|
| 2014 |
Rabin RA, Goodman MS, George TP, Barr MS. Neurobiology of Comorbid Substance Use Disorders in Mental Illness: A Closer Look at the Underlying Commonalities between Cannabis and Schizophrenia Current Addiction Reports. 1: 261-271. DOI: 10.1007/S40429-014-0031-X |
0.404 |
|
| 2014 |
Ouellet-Plamondon C, Mohamed NS, Sharif-Razi M, Simpkin E, George TP. Treatment of Comorbid Tobacco Addiction in Substance Use and Psychiatric Disorders Current Addiction Reports. 1: 61-68. DOI: 10.1007/S40429-013-0001-8 |
0.454 |
|
| 2013 |
Wing VC, Tang YL, Sacco KA, Cubells JF, George TP. Effect of COMT Val(158)Met genotype on nicotine withdrawal-related cognitive dysfunction in smokers with and without schizophrenia. Schizophrenia Research. 150: 602-3. PMID 24084577 DOI: 10.1016/j.schres.2013.09.005 |
0.334 |
|
| 2013 |
Wing VC, Wass CE, Bacher I, Rabin RA, George TP. Varenicline modulates spatial working memory deficits in smokers with schizophrenia. Schizophrenia Research. 149: 190-1. PMID 23849883 DOI: 10.1016/J.Schres.2013.06.032 |
0.362 |
|
| 2013 |
Morisano D, Wing VC, Sacco KA, Arenovich T, George TP. Effects of tobacco smoking on neuropsychological function in schizophrenia in comparison to other psychiatric disorders and non-psychiatric controls. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 22: 46-53. PMID 23398226 DOI: 10.1111/J.1521-0391.2013.00313.X |
0.512 |
|
| 2013 |
Lev-Ran S, Le Foll B, McKenzie K, George TP, Rehm J. Cannabis use and cannabis use disorders among individuals with mental illness. Comprehensive Psychiatry. 54: 589-98. PMID 23375264 DOI: 10.1016/J.Comppsych.2012.12.021 |
0.312 |
|
| 2013 |
Lev-Ran S, Le Foll B, McKenzie K, George TP, Rehm J. Bipolar disorder and co-occurring cannabis use disorders: characteristics, co-morbidities and clinical correlates. Psychiatry Research. 209: 459-65. PMID 23312479 DOI: 10.1016/J.Psychres.2012.12.014 |
0.324 |
|
| 2013 |
Rabin RA, Zakzanis KK, Daskalakis ZJ, George TP. Effects of cannabis use status on cognitive function, in males with schizophrenia. Psychiatry Research. 206: 158-65. PMID 23246245 DOI: 10.1016/J.Psychres.2012.11.019 |
0.343 |
|
| 2013 |
Wing VC, Rabin RA, Wass CE, George TP. Correlations between executive function, decision-making and impulsivity are disrupted in schizophrenia versus controls. Psychiatry Research. 205: 168-71. PMID 23017650 DOI: 10.1016/J.Psychres.2012.08.022 |
0.37 |
|
| 2013 |
Wing VC, Barr MS, Wass CE, Lipsman N, Lozano AM, Daskalakis ZJ, George TP. Brain stimulation methods to treat tobacco addiction. Brain Stimulation. 6: 221-30. PMID 22809824 DOI: 10.1016/J.Brs.2012.06.008 |
0.467 |
|
| 2012 |
Wu BS, Weinberger AH, Mancuso E, Wing VC, Haji-Khamneh B, Levinson AJ, George TP. A Preliminary Feasibility Study of Varenicline for Smoking Cessation in Bipolar Disorder. Journal of Dual Diagnosis. 8: 131-132. PMID 22962546 DOI: 10.1080/15504263.2012.671067 |
0.331 |
|
| 2012 |
Mackowick KM, Lynch MJ, Weinberger AH, George TP. Treatment of tobacco dependence in people with mental health and addictive disorders. Current Psychiatry Reports. 14: 478-85. PMID 22821177 DOI: 10.1007/S11920-012-0299-2 |
0.477 |
|
| 2012 |
George TP, Wu BS, Weinberger AH. A Review of Smoking Cessation in Bipolar Disorder: Implications for Future Research. Journal of Dual Diagnosis. 8: 126-130. PMID 22737046 DOI: 10.1080/15504263.2012.671717 |
0.504 |
|
| 2012 |
Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder. The Journal of Clinical Psychiatry. 73: 654-60. PMID 22697191 DOI: 10.4088/Jcp.11M07522 |
0.52 |
|
| 2012 |
Wing VC, Bacher I, Wu BS, Daskalakis ZJ, George TP. High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia. Schizophrenia Research. 139: 264-6. PMID 22464727 DOI: 10.1016/J.Schres.2012.03.006 |
0.372 |
|
| 2012 |
Weinberger AH, McKee SA, George TP. Smoking cue reactivity in adult smokers with and without depression: a pilot study. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 21: 136-44. PMID 22332857 DOI: 10.1111/J.1521-0391.2011.00203.X |
0.473 |
|
| 2012 |
Wing VC, Wass CE, Soh DW, George TP. A review of neurobiological vulnerability factors and treatment implications for comorbid tobacco dependence in schizophrenia. Annals of the New York Academy of Sciences. 1248: 89-106. PMID 22129082 DOI: 10.1111/J.1749-6632.2011.06261.X |
0.511 |
|
| 2012 |
Wing VC, Moss TG, Rabin RA, George TP. Effects of cigarette smoking status on delay discounting in schizophrenia and healthy controls. Addictive Behaviors. 37: 67-72. PMID 21963152 DOI: 10.1016/J.Addbeh.2011.08.012 |
0.526 |
|
| 2012 |
Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder (The Journal of Clinical Psychiatry (2012) 73, 5 (654-660)) Journal of Clinical Psychiatry. 73: 1035. DOI: 10.4088/Jcp.J12-Lcx07908 |
0.47 |
|
| 2011 |
Barr MS, Farzan F, Wing VC, George TP, Fitzgerald PB, Daskalakis ZJ. Repetitive transcranial magnetic stimulation and drug addiction. International Review of Psychiatry (Abingdon, England). 23: 454-66. PMID 22200135 DOI: 10.3109/09540261.2011.618827 |
0.372 |
|
| 2011 |
Bacher I, Houle S, Xu X, Zawertailo L, Soliman A, Wilson AA, Selby P, George TP, Sacher J, Miler L, Kish SJ, Rusjan P, Meyer JH. Monoamine oxidase A binding in the prefrontal and anterior cingulate cortices during acute withdrawal from heavy cigarette smoking. Archives of General Psychiatry. 68: 817-26. PMID 21810646 DOI: 10.1001/Archgenpsychiatry.2011.82 |
0.421 |
|
| 2011 |
Wing VC, Bacher I, Sacco KA, George TP. Neuropsychological performance in patients with schizophrenia and controls as a function of cigarette smoking status. Psychiatry Research. 188: 320-6. PMID 21669462 DOI: 10.1016/J.Psychres.2011.05.037 |
0.524 |
|
| 2011 |
Rabin RA, Zakzanis KK, George TP. The effects of cannabis use on neurocognition in schizophrenia: a meta-analysis. Schizophrenia Research. 128: 111-6. PMID 21420282 DOI: 10.1016/J.Schres.2011.02.017 |
0.379 |
|
| 2011 |
Sturgess JE, George TP, Kennedy JL, Heinz A, Müller DJ. Pharmacogenetics of alcohol, nicotine and drug addiction treatments. Addiction Biology. 16: 357-76. PMID 21362114 DOI: 10.1111/J.1369-1600.2010.00287.X |
0.378 |
|
| 2011 |
Weinberger AH, George TP, McKee SA. Differences in smoking expectancies in smokers with and without a history of major depression. Addictive Behaviors. 36: 434-7. PMID 21239119 DOI: 10.1016/J.Addbeh.2010.12.024 |
0.45 |
|
| 2011 |
Wing VC, Sacco KA, George TP. Spatial working memory impairments induced by cigarette smoking abstinence are correlated with plasma nicotine levels in schizophrenia. Schizophrenia Research. 128: 171-2. PMID 21075601 DOI: 10.1016/J.Schres.2010.10.011 |
0.467 |
|
| 2010 |
Voci S, Bondy S, Zawertailo L, Walker L, George TP, Selby P. Impact of a smoke-free policy in a large psychiatric hospital on staff attitudes and patient behavior. General Hospital Psychiatry. 32: 623-30. PMID 21112455 DOI: 10.1016/J.Genhosppsych.2010.08.005 |
0.368 |
|
| 2010 |
Moss TG, Weinberger AH, Vessicchio JC, Mancuso V, Cushing SJ, Pett M, Kitchen K, Selby P, George TP. A tobacco reconceptualization in psychiatry: toward the development of tobacco-free psychiatric facilities. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 19: 293-311. PMID 20653636 DOI: 10.1111/J.1521-0391.2010.00051.X |
0.49 |
|
| 2010 |
Weinberger AH, McKee SA, George TP. Changes in smoking expectancies in abstinent, reducing, and non-abstinent participants during a pharmacological trial for smoking cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 937-43. PMID 20644207 DOI: 10.1093/Ntr/Ntq120 |
0.483 |
|
| 2010 |
Selby P, Voci SC, Zawertailo LA, George TP, Brands B. Individualized smoking cessation treatment in an outpatient setting: Predictors of outcome in a sample with psychiatric and addictions co-morbidity. Addictive Behaviors. 35: 811-7. PMID 20488624 DOI: 10.1016/J.Addbeh.2010.03.020 |
0.517 |
|
| 2010 |
Ismail Z, Syms J, Blumberger D, George TP. Varenicline induced polydipsia and hyponatremia in a patient with schizophrenia. Schizophrenia Research. 119: 268. PMID 20178890 DOI: 10.1016/J.Schres.2010.01.027 |
0.338 |
|
| 2010 |
Weinberger AH, Reutenauer EL, Jatlow PI, O'Malley SS, Potenza MN, George TP. A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers. Drug and Alcohol Dependence. 107: 188-95. PMID 19939587 DOI: 10.1016/J.Drugalcdep.2009.10.009 |
0.484 |
|
| 2010 |
Lising-Enriquez K, Blank D, Cushing SJ, Bacher IC, George TP. Treatment of co-morbid cocaine dependence in schizophrenia with topiramate. Schizophrenia Research. 116: 97. PMID 19854620 DOI: 10.1016/J.Schres.2009.09.040 |
0.323 |
|
| 2010 |
Wu BS, George TP. Pharmacotherapies for nicotine addiction in adults and adolescents Journal of Pediatric Biochemistry. 1: 165-174. DOI: 10.3233/Jpb-2010-0016 |
0.448 |
|
| 2009 |
Weinberger AH, George TP, Perkins KA, Chengappa KN. Effects of Topiramate on Smoking in Patients with Schizoaffective Disorder, Bipolar Type: Response to Khazaal and Zullino. Journal of Clinical Psychopharmacology. 29: 193-194. PMID 25506116 DOI: 10.1097/Jcp.0B013E31819C57D4 |
0.51 |
|
| 2009 |
Weinberger AH, Hitsman B, Papandonatos GD, Sacco KA, Vessicchio JC, George TP. Predictors of abstinence and changes in psychiatric symptoms in a pooled sample of smokers with schizophrenia receiving combination pharmacotherapy and behavioral therapy for smoking cessation. Journal of Clinical Psychopharmacology. 29: 601-3. PMID 19910728 DOI: 10.1097/Jcp.0B013E3181Bfd0B4 |
0.519 |
|
| 2009 |
Bacher I, Wu B, Shytle DR, George TP. Mecamylamine - a nicotinic acetylcholine receptor antagonist with potential for the treatment of neuropsychiatric disorders. Expert Opinion On Pharmacotherapy. 10: 2709-21. PMID 19874251 DOI: 10.1517/14656560903329102 |
0.373 |
|
| 2009 |
McKee SA, Weinberger AH, Harrison EL, Coppola S, George TP. Effects of the nicotinic receptor antagonist mecamylamine on ad-lib smoking behavior, topography, and nicotine levels in smokers with and without schizophrenia: a preliminary study. Schizophrenia Research. 115: 317-24. PMID 19700263 DOI: 10.1016/J.Schres.2009.07.019 |
0.537 |
|
| 2009 |
Rabin RA, Sacco KA, George TP. Correlation of prepulse inhibition and Wisconsin Card Sorting Test in schizophrenia and controls: effects of smoking status. Schizophrenia Research. 114: 91-7. PMID 19656658 DOI: 10.1016/J.Schres.2009.07.006 |
0.509 |
|
| 2009 |
Daskalakis ZJ, George TP. Clozapine, GABA(B), and the treatment of resistant schizophrenia. Clinical Pharmacology and Therapeutics. 86: 442-6. PMID 19626000 DOI: 10.1038/Clpt.2009.115 |
0.347 |
|
| 2009 |
Hitsman B, Moss TG, Montoya ID, George TP. Treatment of tobacco dependence in mental health and addictive disorders. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 368-78. PMID 19527557 DOI: 10.1177/070674370905400604 |
0.493 |
|
| 2009 |
Morisano D, Bacher I, Audrain-McGovern J, George TP. Mechanisms underlying the comorbidity of tobacco use in mental health and addictive disorders. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 356-67. PMID 19527556 DOI: 10.1177/070674370905400603 |
0.395 |
|
| 2009 |
George TP, Ziedonis DM. Addressing tobacco dependence in psychiatric practice: promises and pitfalls. Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie. 54: 353-5. PMID 19527555 DOI: 10.1177/070674370905400602 |
0.525 |
|
| 2009 |
Moss TG, Sacco KA, Allen TM, Weinberger AH, Vessicchio JC, George TP. Prefrontal cognitive dysfunction is associated with tobacco dependence treatment failure in smokers with schizophrenia. Drug and Alcohol Dependence. 104: 94-9. PMID 19447570 DOI: 10.1016/J.Drugalcdep.2009.04.005 |
0.549 |
|
| 2009 |
Woznica AA, Sacco KA, George TP. Prepulse inhibition deficits in schizophrenia are modified by smoking status. Schizophrenia Research. 112: 86-90. PMID 19423298 DOI: 10.1016/J.Schres.2009.04.016 |
0.527 |
|
| 2009 |
Yip SW, Sacco KA, George TP, Potenza MN. Risk/reward decision-making in schizophrenia: a preliminary examination of the influence of tobacco smoking and relationship to Wisconsin Card Sorting Task performance. Schizophrenia Research. 110: 156-64. PMID 19269138 DOI: 10.1016/J.Schres.2009.01.012 |
0.388 |
|
| 2009 |
Sacco KA, Creeden C, Reutenauer EL, Vessicchio JC, Weinberger AH, George TP. Effects of atomoxetine on cognitive function and cigarette smoking in schizophrenia. Schizophrenia Research. 107: 332-3. PMID 18995989 DOI: 10.1016/J.Schres.2008.09.026 |
0.497 |
|
| 2009 |
Lambe EK, George TP. Perspective: Translational studies on glutamate and dopamine neurocircuitry in addictions: implications for addiction treatment. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 255-6. PMID 18987625 DOI: 10.1038/Npp.2008.196 |
0.335 |
|
| 2009 |
Bacher IC, Hitsman B, George TP. RE: Smoking tobacco and collective myopia Canadian Journal of Psychiatry. 54: 855-856. DOI: 10.1177/070674370905401214 |
0.478 |
|
| 2009 |
Woznica AA, George TP. Exploiting nicotinic receptor mechanisms for the treatment of schizophrenia and depression Journal of Dual Diagnosis. 5: 159-167. DOI: 10.1080/15504260902869311 |
0.468 |
|
| 2008 |
Barr MS, Fitzgerald PB, Farzan F, George TP, Daskalakis ZJ. Transcranial magnetic stimulation to understand the pathophysiology and treatment of substance use disorders. Current Drug Abuse Reviews. 1: 328-39. PMID 19630729 DOI: 10.2174/1874473710801030328 |
0.367 |
|
| 2008 |
Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, Breslau N, Brown RA, George TP, Williams J, Calhoun PS, Riley WT. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1691-715. PMID 19023823 DOI: 10.1080/14622200802443569 |
0.491 |
|
| 2008 |
Weinberger AH, Vessicchio JC, Sacco KA, Creeden CL, Chengappa KN, George TP. A preliminary study of sustained-release bupropion for smoking cessation in bipolar disorder. Journal of Clinical Psychopharmacology. 28: 584-7. PMID 18794666 DOI: 10.1097/Jcp.0B013E318184Ba3C |
0.453 |
|
| 2008 |
Sacco KA, Creeden C, Reutenauer EL, George TP. Effects of galantamine on cognitive deficits in smokers and non-smokers with schizophrenia. Schizophrenia Research. 103: 326-7. PMID 18571377 DOI: 10.1016/J.Schres.2008.05.004 |
0.455 |
|
| 2008 |
Smith AE, Cavallo DA, Dahl T, Wu R, George TP, Krishnan-Sarin S. Effects of acute tobacco abstinence in adolescent smokers compared with nonsmokers. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. 43: 46-54. PMID 18565437 DOI: 10.1016/J.Jadohealth.2007.12.004 |
0.476 |
|
| 2008 |
Weinberger AH, Reutenauer EL, Vessicchio JC, George TP. Survey of clinician attitudes toward smoking cessation for psychiatric and substance abusing clients. Journal of Addictive Diseases. 27: 55-63. PMID 18551888 DOI: 10.1300/J069V27N01_06 |
0.488 |
|
| 2008 |
George TP, Sacco KA, Vessicchio JC, Weinberger AH, Shytle RD. Nicotinic antagonist augmentation of selective serotonin reuptake inhibitor-refractory major depressive disorder: a preliminary study. Journal of Clinical Psychopharmacology. 28: 340-4. PMID 18480694 DOI: 10.1097/Jcp.0B013E318172B49E |
0.394 |
|
| 2008 |
Weinberger AH, George TP, Perkins KA, Chengappa KN. Effects of topiramate on smoking in patients with schizoaffective disorder, bipolar type. Journal of Clinical Psychopharmacology. 28: 247-8. PMID 18344743 DOI: 10.1097/Jcp.0B013E31816740Cf |
0.496 |
|
| 2008 |
George TP, Vessicchio JC, Sacco KA, Weinberger AH, Dudas MM, Allen TM, Creeden CL, Potenza MN, Feingold A, Jatlow PI. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biological Psychiatry. 63: 1092-6. PMID 18096137 DOI: 10.1016/J.Biopsych.2007.11.002 |
0.528 |
|
| 2008 |
George TP, Weinberger AH. Monoamine oxidase inhibition for tobacco pharmacotherapy. Clinical Pharmacology and Therapeutics. 83: 619-21. PMID 18091758 DOI: 10.1038/Sj.Clpt.6100474 |
0.485 |
|
| 2007 |
Toll BA, O'Malley SS, Katulak NA, Wu R, Dubin JA, Latimer A, Meandzija B, George TP, Jatlow P, Cooney JL, Salovey P. Comparing gain- and loss-framed messages for smoking cessation with sustained-release bupropion: a randomized controlled trial. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 21: 534-44. PMID 18072836 DOI: 10.1037/0893-164X.21.4.534 |
0.44 |
|
| 2007 |
Le Foll B, George TP. Treatment of tobacco dependence: integrating recent progress into practice. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 177: 1373-80. PMID 18025429 DOI: 10.1503/Cmaj.070627 |
0.444 |
|
| 2007 |
Sacco KA, Head CA, Vessicchio JC, Easton CJ, Prigerson HG, George TP. Adverse childhood experiences, smoking and mental illness in adulthood: a preliminary study. Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists. 19: 89-97. PMID 17612848 DOI: 10.1080/10401230701334762 |
0.444 |
|
| 2007 |
Gershon Grand RB, Hwang S, Han J, George T, Brody AL. Short-term naturalistic treatment outcomes in cigarette smokers with substance abuse and/or mental illness. The Journal of Clinical Psychiatry. 68: 892-8; quiz 980-1. PMID 17592914 DOI: 10.4088/Jcp.V68N0611 |
0.515 |
|
| 2007 |
Easton CJ, Weinberger AH, George TP. Age of onset of smoking among alcohol dependent men attending substance abuse treatment after a domestic violence arrest. Addictive Behaviors. 32: 2020-31. PMID 17300874 DOI: 10.1016/J.Addbeh.2007.01.021 |
0.481 |
|
| 2007 |
Weinberger AH, Sacco KA, Creeden CL, Vessicchio JC, Jatlow PI, George TP. Effects of acute abstinence, reinstatement, and mecamylamine on biochemical and behavioral measures of cigarette smoking in schizophrenia. Schizophrenia Research. 91: 217-25. PMID 17293085 DOI: 10.1016/J.Schres.2006.12.007 |
0.524 |
|
| 2007 |
Weinberger AH, Reutenauer EL, Allen TM, Termine A, Vessicchio JC, Sacco KA, Easton CJ, McKee SA, George TP. Reliability of the Fagerström Test for Nicotine Dependence, Minnesota Nicotine Withdrawal Scale, and Tiffany Questionnaire for Smoking Urges in smokers with and without schizophrenia. Drug and Alcohol Dependence. 86: 278-82. PMID 16876968 DOI: 10.1016/J.Drugalcdep.2006.06.005 |
0.504 |
|
| 2007 |
Tang YL, George TP, Mao PX, Cai ZJ, Chen Q. Cigarette smoking in Chinese male inpatients with schizophrenia: a cross-sectional analysis. Journal of Psychiatric Research. 41: 43-8. PMID 16360170 DOI: 10.1016/J.Jpsychires.2005.10.009 |
0.506 |
|
| 2007 |
Weinberger AH, Creeden CL, Sacco KA, George TP. Neurocognitive effects of nicotine and tobacco in individuals with schizophrenia Journal of Dual Diagnosis. 3: 61-77. DOI: 10.1300/J374V03N03_06 |
0.466 |
|
| 2007 |
George TP. Neurobiological links between nicotine addiction and schizophrenia Journal of Dual Diagnosis. 3: 27-42. DOI: 10.1300/J374V03N03_04 |
0.435 |
|
| 2006 |
George TP, Termine A, Sacco KA, Allen TM, Reutenauer E, Vessicchio JC, Duncan EJ. A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophrenia Research. 87: 307-15. PMID 16854565 DOI: 10.1016/J.Schres.2006.05.022 |
0.546 |
|
| 2006 |
Sacco KA, Termine A, Dudas MM, Seyal AA, Allen TM, Vessicchio JC, Wexler BE, George TP. Neuropsychological deficits in nonsmokers with schizophrenia: effects of a nicotinic antagonist. Schizophrenia Research. 85: 213-21. PMID 16678390 DOI: 10.1016/J.Schres.2006.03.025 |
0.452 |
|
| 2005 |
Kalman D, Morissette SB, George TP. Co-morbidity of smoking in patients with psychiatric and substance use disorders. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 14: 106-23. PMID 16019961 DOI: 10.1080/10550490590924728 |
0.331 |
|
| 2005 |
Sacco KA, Termine A, Seyal A, Dudas MM, Vessicchio JC, Krishnan-Sarin S, Jatlow PI, Wexler BE, George TP. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Archives of General Psychiatry. 62: 649-59. PMID 15939842 DOI: 10.1001/Archpsyc.62.6.649 |
0.547 |
|
| 2005 |
Fonder MA, Sacco KA, Termine A, Boland BS, Seyal AA, Dudas MM, Vessicchio JC, George TP. Smoking cue reactivity in schizophrenia: effects of a nicotinic receptor antagonist. Biological Psychiatry. 57: 802-8. PMID 15820238 DOI: 10.1016/J.Biopsych.2004.12.027 |
0.519 |
|
| 2005 |
Duhig AM, Cavallo DA, McKee SA, George TP, Krishnan-Sarin S. Daily patterns of alcohol, cigarette, and marijuana use in adolescent smokers and nonsmokers. Addictive Behaviors. 30: 271-83. PMID 15621398 DOI: 10.1016/J.Addbeh.2004.05.016 |
0.387 |
|
| 2004 |
Potenza MN, Steinberg MA, McLaughlin SD, Wu R, Rounsaville BJ, Krishnan-Sarin S, George TP, O'Malley SS. Characteristics of tobacco-smoking problem gamblers calling a gambling helpline. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. 13: 471-93. PMID 15764425 DOI: 10.1080/10550490490483044 |
0.456 |
|
| 2004 |
Sacco KA, Bannon KL, George TP. Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders. Journal of Psychopharmacology (Oxford, England). 18: 457-74. PMID 15582913 DOI: 10.1177/0269881104047273 |
0.459 |
|
| 2004 |
Dolan SL, Sacco KA, Termine A, Seyal AA, Dudas MM, Vessicchio JC, Wexler BE, George TP. Neuropsychological deficits are associated with smoking cessation treatment failure in patients with schizophrenia. Schizophrenia Research. 70: 263-75. PMID 15329302 DOI: 10.1016/J.Schres.2004.01.006 |
0.513 |
|
| 2004 |
George TP, O'Malley SS. Current pharmacological treatments for nicotine dependence. Trends in Pharmacological Sciences. 25: 42-8. PMID 14723978 DOI: 10.1016/J.Tips.2003.11.003 |
0.489 |
|
| 2003 |
George TP, Vessicchio JC, Termine A, Jatlow PI, Kosten TR, O'Malley SS. A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessation. Biological Psychiatry. 53: 136-43. PMID 12547469 DOI: 10.1016/S0006-3223(02)01454-3 |
0.478 |
|
| 2002 |
Leonard S, Giordano L, George TP, Vessicchio JC, Termine A, Seyal A, Boland BS, Fonder MA, Kosten TR, Wexler BE. Are differential behavioral responses to smoking and smoking cessation in schizophrenia related to nicotinic receptor levels? [1] (multiple letters) Neuropsychopharmacology. 27: 1082-1085. PMID 12464465 DOI: 10.1016/S0893-133X(02)00382-2 |
0.421 |
|
| 2002 |
Vessicchio JC, Termine A, George TP. Smoking cessation and panic attacks: a report of 2 cases. The Journal of Clinical Psychiatry. 63: 594-5. PMID 12143916 DOI: 10.4088/Jcp.V63N0710B |
0.437 |
|
| 2002 |
George TP, Vessicchio JC, Termine A, Bregartner TA, Feingold A, Rounsaville BJ, Kosten TR. A placebo controlled trial of bupropion for smoking cessation in schizophrenia. Biological Psychiatry. 52: 53-61. PMID 12079730 DOI: 10.1016/S0006-3223(02)01339-2 |
0.539 |
|
| 2002 |
Kosten TR, George TP, Kosten TA. The potential of dopamine agonists in drug addiction. Expert Opinion On Investigational Drugs. 11: 491-9. PMID 11922858 DOI: 10.1517/13543784.11.4.491 |
0.315 |
|
| 2002 |
George TP, Vessicchio JC, Termine A, Sahady DM, Head CA, Pepper WT, Kosten TR, Wexler BE. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 75-85. PMID 11751034 DOI: 10.1016/S0893-133X(01)00296-2 |
0.528 |
|
| 2002 |
George TP, Vessicchio JC. Treating tobacco addiction in schizophrenia: Where do we go from here? Addiction. 97: 795-796. DOI: 10.1046/J.1360-0443.2002.00154.X |
0.45 |
|
| 2001 |
Young JM, Shytle RD, Sanberg PR, George TP. Mecamylamine: new therapeutic uses and toxicity/risk profile. Clinical Therapeutics. 23: 532-65. PMID 11354389 DOI: 10.1016/S0149-2918(01)80059-X |
0.302 |
|
| 2000 |
George TP, Ziedonis DM, Feingold A, Pepper WT, Satterburg CA, Winkel J, Rounsaville BJ, Kosten TR. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. The American Journal of Psychiatry. 157: 1835-42. PMID 11058482 DOI: 10.1176/Appi.Ajp.157.11.1835 |
0.533 |
|
| 2000 |
George TP, Verrico CD, Xu L, Roth RH. Effects of repeated nicotine administration and footshock stress on rat mesoprefrontal dopamine systems: Evidence for opioid mechanisms. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 23: 79-88. PMID 10869888 DOI: 10.1016/S0893-133X(99)00165-7 |
0.312 |
|
| 2000 |
George T, Pepper W, Vessicchio J, Termine A, Jackson T, Wexler B, Kosten T. 66. Neuropsychological function during smoking cessation in schizophrenia Biological Psychiatry. 47: S20. DOI: 10.1016/S0006-3223(00)00328-0 |
0.503 |
|
| 1998 |
George TP, Verrico CD, Roth RH. Effects of repeated nicotine pre-treatment on mesoprefrontal dopaminergic and behavioral responses to acute footshock stress. Brain Research. 801: 36-49. PMID 9729261 DOI: 10.1016/S0006-8993(98)00537-X |
0.334 |
|
| 1997 |
Ziedonis DM, George TP. Schizophrenia and nicotine use: report of a pilot smoking cessation program and review of neurobiological and clinical issues. Schizophrenia Bulletin. 23: 247-54. PMID 9165635 DOI: 10.1093/Schbul/23.2.247 |
0.507 |
|
| 1996 |
George TP, Spence MW. Alterations of membrane phospholipid metabolism in patients with schizophrenia assessed by phosphorus magnetic resonance spectroscopy. Archives of General Psychiatry. 53: 1065-6. PMID 8911233 DOI: 10.1001/Archpsyc.1996.01830110103020 |
0.304 |
|
| 1995 |
George TP, Sernyak MJ, Ziedonis DM, Woods SW. Effects of clozapine on smoking in chronic schizophrenic outpatients. The Journal of Clinical Psychiatry. 56: 344-6. PMID 7635849 |
0.386 |
|
| Show low-probability matches. |